3 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 0.6% per year over the past 2 years.
Net income has grown faster than revenue (11.3% vs 0.6% per year).
Operating margin has been roughly flat, at 16.1% in the latest year.
Free cash flow has grown 0.5% per year over the past 2 years.
Financial health
Total debt ($5.3B) exceeds cash ($1.9B); net debt is $3.3B.
Operating income covered interest expense 4.1× in the latest year, up from 3.3× 2 years ago.
Total debt is 2.0× EBITDA.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$11.8B
$1.2B
25.7%
16.1%
$1.4B
$5.3B
$1.9B
2024
$11.7B
$1.3B
26.2%
18.8%
$1.6B
—
$1.6B
2023
$11.7B
$956M
23.7%
16.2%
$1.4B
—
—
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$2.2B
-$116M
9.7%
-3.5%
-$1.2B
$6.0B
$1.1B
Dec '25
$2.8B
$298M
26.8%
16.7%
$1.6B
$5.3B
$1.9B
Sep '25
$3.7B
$545M
29.6%
21.2%
$669M
—
$826M
Jun '25
$3.2B
$429M
30.0%
20.8%
—
—
$601M
Mar '25
$2.1B
-$87M
10.7%
-0.8%
-$1.1B
—
—
Dec '24
$2.8B
$291M
27.3%
18.8%
$1.6B
—
$1.6B
Sep '24
$3.4B
$553M
30.2%
24.5%
$402M
—
—
Jun '24
$3.2B
$474M
30.2%
23.3%
—
—
—
Valuation over time
How the market has priced AMRZ against its own fundamentals since 2025-06 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has risen from 21.5× (Jun '25) to 26.1× (Jun '26).
The price-to-sales ratio has risen from 2.3× (Jun '25) to 2.6× (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is AMRZ growing its revenue and profit?
Over the past 2 years, Amrize Ltd's revenue has grown 0.6% per year, and net income grown 11.3% per year. These are computed facts, not advice.
How much debt does AMRZ have?
As of FY2025, Amrize Ltd reported $5.3B of total debt against $1.9B of cash; operating income covered interest expense 4.1×.
What is AMRZ's profit margin?
In FY2025, gross margin was 25.7%, operating margin 16.1%, and net margin 10.0%.
What is AMRZ's P/E ratio?
As of Jun '26, Amrize Ltd traded at a price-to-earnings ratio of about 26.1× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.